Atlas Trials

Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients

Clinical trial NCT01430572 · COMPLETED

Trial details

NCT number
NCT01430572
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced CancersSolid Tumors
Start date
2011-10-07
Primary completion
2020-05-12
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.